(Q39511378)

12 September 2017

Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines (English)

1 reference

12 September 2017

0 references

C M Ausiello

1

1 reference

12 September 2017

R Lande

2

1 reference

12 September 2017

F Urbani

3

1 reference

12 September 2017

A la Sala

4

1 reference

12 September 2017

P Stefanelli

5

1 reference

12 September 2017

S Salmaso

6

1 reference

12 September 2017

P Mastrantonio

7

1 reference

12 September 2017

A Cassone

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

12 September 2017

Infection and Immunity

1 reference

12 September 2017

67

1 reference

12 September 2017

8

1 reference

12 September 2017

4064-4071

1 reference

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Pertussis: current concepts of pathogenesis and prevention

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Prevalence of markers of exposure to Bordetella pertussis among Italian young adults.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

ESEN : a comparison of vaccination programmes Part two : pertussis

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96703

Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance

2 December 2018

1 reference

12 December 2020

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group

1 reference

12 December 2020

Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children

1 reference

12 December 2020

Observer bias in acellular pertussis vaccine trials

1 reference

12 December 2020

Pertussis Antibodies, Protection, and Vaccine Efficacy After Household Exposure

1 reference

12 December 2020

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

12 December 2020

VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Lee

1 reference

12 December 2020

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials

1 reference

12 December 2020

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

1 reference

12 December 2020

Comparison of 13 acellular pertussis vaccines: overview and serologic response

1 reference

12 December 2020

Characterization of fimbrial subunits from Bordetella species

1 reference

12 December 2020

Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis

1 reference

12 December 2020

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

12 December 2020

Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

12 December 2020

Secretion of IFN-γ, IL-6, Granulocyte-Macrophage Colony-Stimulating Factor and IL-10 Cytokines after Activation of Human Purified T Lymphocytes upon CD38 Ligation

1 reference

12 December 2020

Identifiers

1 reference

12 September 2017

PubMed publication ID

10417175

1 reference